HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Correlation of plasma thioredoxin reductase activity to growth of H22 hepatocellular carcinoma xenografts in Kunming mice].

AbstractBACKGROUND AND OBJECTIVE:
The expression and activity of thioredoxin reductase (TrxR) are significantly higher in tumor tissues than in normal tissues, but the correlation of plasma TrxR activity to tumor growth has seldom been reported. This study was to evaluate the correlation of plasma TrxR activity to the growth of hepatocellular carcinoma (HCC) H22 cell xenografts in mice.
METHODS:
H22 cells were injected subcutaneously into Kunming mice to establish HCC model. The mice were divided into control group, mice group, low dose (36 mg/kg), moderate dose (72 mg/kg) and high dose (216 mg/kg) ethaselen groups. The mice in control group and model group were given 0.5% sodium carboxymethyl cellulose (CMC-Na). Blood samples were drawn before tumor cell inoculation, when tumor volume reached 100 mm3, and at Days 1, 4 and 10 of treatment. TrxR activity in plasma and tumor tissues was detected by dithio-bis-nitrobenzoic acid (DTNB) method.
RESULTS:
The inhibition rates of tumor growth were 59.5% in low dose ethaselen group, 74.3% in moderate dose ethaselen group, and 74.9% in high dose ethaselen group. Plasma TrxR activity was stable in control mice, and was correlated positively to tumor volume in tumor-bearing mice. At the end of treatment, the inhibition rates of TrxR activity in plasma and tumor were 59.2% and 15.3% in low dose ethaselen group, 68.4% and 25.8% in moderate dose ethaselen group, 68.9% and 29.8% in high dose ethaselen group.
CONCLUSIONS:
Plasma TrxR activity is correlated positively to tumor growth. Ethaselen can inhibit TrxR activity corresponding to tumor growth inhibition.
AuthorsQiang Tan, Xiao-Yuan Ren, Jing Li, Fang Wang, Sheng-Ju Deng, Hui-Hui Zeng
JournalAi zheng = Aizheng = Chinese journal of cancer (Ai Zheng) Vol. 28 Issue 5 Pg. 472-7 (May 2009) China
PMID19624873 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • (1,2-bis(1,2-benzisoselenazolone-3(2H)-ketone))ethane
  • Antineoplastic Agents
  • Bridged Bicyclo Compounds, Heterocyclic
  • Organoselenium Compounds
  • Thioredoxin-Disulfide Reductase
Topics
  • Animals
  • Antineoplastic Agents (administration & dosage, pharmacology)
  • Bridged Bicyclo Compounds, Heterocyclic (administration & dosage, pharmacology)
  • Carcinoma, Hepatocellular (blood, enzymology, metabolism, pathology)
  • Cell Line, Tumor
  • Dose-Response Relationship, Drug
  • Humans
  • Liver Neoplasms (blood, enzymology, metabolism, pathology)
  • Male
  • Mice
  • Neoplasm Transplantation
  • Organoselenium Compounds (administration & dosage, pharmacology)
  • Thioredoxin-Disulfide Reductase (antagonists & inhibitors, blood, metabolism)
  • Tumor Burden (drug effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: